Gene · 6118
Papers2,490
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1 to 20 of 2,490
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| BUB1 and CDK4/6 Dual Inhibition Increases Radiation Sensitivity in Glioblastoma, Lung Cancer, and Triple-Negative Breast Cancer. | Biomedicines | 2026 | 42792682 | PubTator, text mining | PubMed |
| Nanoparticle Co-delivery of Microtubule Inhibitors and Cisplatin Overcomes DNA Repair-Mediated Resistance in Head and Neck Cancer. | Mol Cancer Ther | 2026 | 42777141 | PubTator, text mining | PubMed |
| The KEAP1-NFE2L2/NRF2 Axis in Non-Small Cell Lung Cancer Radioresistance: Redox Homeostasis and Emerging DNA Damage Response Mechanisms. | Cancer Manag Res | 2026 | 42708106 | PubTator, text mining | PubMed |
| Corrigendum to "CSDE1 enhances genotoxic drug resistance in cancer by modulating RPA2 through the CSDE1-eIF3a regulatory complex" [Drug Resist. Updat. 81 (2025) 101249]. | Drug Resist Updat | 2026 | 42632763 | PubTator, text mining | PubMed |
| The tumor suppressor menin is a key scaffold mediator for homologous recombination repair. | Nucleic Acids Res | 2026 | 42578372 | PubTator, text mining | PubMed |
| Fission yeast RPA-TERT-Tpz1TPP1 complex promotes telomere extension and suppresses telomere recombination. | bioRxiv | 2026 | 42539071 | PubTator, text mining | PubMed |
| EFHD2 drives lactate-mediated DNA damage repair and immunosuppression via HMGB1 and HIF-1α to confer radioresistance in colorectal cancer. | Cell Death Dis | 2026 | 42336814 | PubTator, text mining | PubMed |
| TEAD1 condensates are transcriptionally inactive storage sites on the pericentromeric heterochromatin in cancer cells. | Nat Cell Biol | 2026 | 42277434 | PubTator, text mining | PubMed |
| A RHNO1-ATR/Chk1 positive feedback loop sustains the DNA replication stress response. | bioRxiv | 2026 | 42239230 | PubTator, text mining | PubMed |
| Combination of CHK1 and CHK2 inhibitors exerts synergistic antitumor effects against neuroblastoma cells. | Pediatr Res | 2026 | 42230907 | PubTator, text mining | PubMed |
| Association of DNA damage repair related genes with prostate cancer: A multi-omics Mendelian Randomization analysis. | Medicine (Baltimore) | 2026 | 42216412 | PubTator, text mining | PubMed |
| Hypoxia and DNA-Repair Radiosensitivity Signatures Are Associated with Radiotherapy-Modified Survival in TCGA Breast Cancer, with External Prognostic Validation of the Hypoxia Score in METABRIC. | BioTech (Basel) | 2026 | 42029580 | PubTator, text mining | PubMed |
| RNF126 and BRAP safeguard genome integrity after DNA damage in late mitosis. | Cell Rep | 2026 | 41996237 | PubTator, text mining | PubMed |
| RPA hyperphosphorylation hinders the resolution of R-loops and G-quadruplex-associated R-loops during RAS-driven senescence. | Nucleic Acids Res | 2026 | 41978259 | PubTator, text mining | PubMed |
| PRMT5 is Frequently Upregulated and a Potential Therapeutic Target in MTAP-deficient Malignant Peripheral Nerve Sheath Tumors. | bioRxiv | 2026 | 41959302 | PubTator, text mining | PubMed |
| PFOS-mediated suppression of SOX30 impairs DNA double-strand break repair leading to male reproductive dysfunction. | Ecotoxicol Environ Saf | 2026 | 41905031 | PubTator, text mining | PubMed |
| CHK1 is an integral regulator of DNA replication in human cells. | Cell Death Dis | 2026 | 41888112 | PubTator, text mining | PubMed |
| Importin α characterizes a micronuclear environment associated with genomic instability in human cancer cells. | J Cell Sci | 2026 | 41834705 | PubTator, text mining | PubMed |
| WNT7B drives a program for pancreatic cancer subtype switching and progression. | iScience | 2026 | 41797924 | PubTator, text mining | PubMed |
| Overcoming acquired doxorubicin resistance of ovarian carcinoma cells by verapamil‑mediated promotion of DNA damage‑driven cytotoxicity. | Int J Oncol | 2026 | 41789585 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/6118/papers